The present invention relates to pharmacology and can be used for the preparation of a medicament for viral induced immunodeficiency, as well as for the treatment and prevention of viral diseases such as herpes virus, influenza, B and C hepatitis viruses and the like. Biologically active substances of pharmacological action extracted from the green parts of the genus Gramineae, Calamagrostis Adans and / or the genus Deshampsia Beauv and the small spines are selected from the group consisting of flavonoids, tricine flavonoid aglycones, apigenin, luteolin, quercetin, lanazin and / , Apigenin, luteolin, quercetin, lanazin, adjuvant and the like, and has the following composition: 0.016 to 2062% tricine flavonoid aglycon and / or flavonoid glycoside； 0.010-1393% aglycone flavonoid apigenin and / or its flavonoid glycosides； 0.01 to 4,979% aglycone flavonoid luteolin and / or its flavonoid glycoside； 0,001 to 0,771% quercetin flavonoid aglycone and / or its flavonoid glycoside； 0,104 to 0,203% aglycone flavonoid lanagazine and / or its flavonoid glycosides； 99,868 to 90,592%. Thus, determining the physico-chemical specific composition of the biologically active material and active material to improve the biologically active material results in the production of the optimal composition for viral antitumor activity against the virus and the determination of the dosage (Fig. 1). In addition, biologically active substance was judged to be an inducer of (γ) type, and it was found that it has an effect of regulating apoptosis and has an antioxidant property and increases cell resistance to free radical stress. There is an antiviral action against specific viruses such as type 2 herpes, influenza virus, and hepatitis C virus.본 발명은 약리학에 관한 것으로서 헤르페스 바이러스, 인풀루엔자, B형 및 C형 간염 바이러스 등으로 발생하는 바이러스성 질병 치료 및 예방뿐만 아니라 바이러스성 유도면역결핍증용 약제 제조에 사용될 수 있다.Gramineae, Calamagrostis Adans 속 및/또는 Deshampsia Beauv 속의 녹색 부분 및 작은 이삭으로부터 추출된 약학적 작용의 생물학적 활성 물질은 플라보노이드, 트리신 플라보노이드 아글리콘, 아피제닌, 루테올린, 케르
